AVITA Medical, Inc. (RCEL) Tops Q3 EPS by 11c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.22), $0.11 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $9.09 million versus the consensus estimate of $7.47 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Golar LNG (GLNG) reports Q2 results
• Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance